In this regard, Srinivasan et al. [30] have recently proposed that the identification of biallelic mutations of genes involved in DNA repair in cancer tissues, such as BAP1, should be routinely performed for all patients so as to prospectively evaluate the effectiveness of personalized therapies. Here, BAP1 is linked to cancer.